These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28718542)

  • 1. Intravitreal Bevacizumab: Indications And Complications.
    Jan S; Nazim M; Karim S; Hussain Z
    J Ayub Med Coll Abbottabad; 2016; 28(2):364-368. PubMed ID: 28718542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).
    Wu L; Martínez-Castellanos MA; Quiroz-Mercado H; Arevalo JF; Berrocal MH; Farah ME; Maia M; Roca JA; Rodriguez FJ;
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):81-7. PubMed ID: 17674014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
    Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world evidence of safety profile of intravitreal bevacizumab (Avastin) in an Indian scenario.
    Jain P; Sheth J; Anantharaman G; Gopalakrishnan M
    Indian J Ophthalmol; 2017 Jul; 65(7):596-602. PubMed ID: 28724817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
    Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
    Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The early effects of intravitreal anti vascular endothelial growth factor agents on intraocular pressure and central corneal thickness.
    Omay E; Elgin U; Sen E; Yilmazbas P
    Int Ophthalmol; 2016 Oct; 36(5):665-70. PubMed ID: 26780098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal Bevacizumab in Diabetic Retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 Knobloch Lecture.
    Arevalo JF; Liu TYA;
    Asia Pac J Ophthalmol (Phila); 2018; 7(1):36-39. PubMed ID: 29280367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease.
    Wong LJ; Desai RU; Jain A; Feliciano D; Moshfeghi DM; Sanislo SR; Blumenkranz MS
    Retina; 2008 Oct; 28(8):1151-8. PubMed ID: 18685542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month changes in cytokine levels after intravitreal bevacizumab injection for diabetic macular oedema and macular oedema due to central retinal vein occlusion.
    Wen J; Jiang Y; Zheng X; Zhou Y
    Br J Ophthalmol; 2015 Oct; 99(10):1334-40. PubMed ID: 25841235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Results From the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-up.
    Arevalo JF; Lasave AF; Wu L; Maia M; Diaz-Llopis M; Alezzandrini AA; Brito M;
    Retina; 2017 Feb; 37(2):334-343. PubMed ID: 27429384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and complications of intravitreal injections performed in an Asian population in Singapore.
    Xu Y; Tan CS
    Int Ophthalmol; 2017 Apr; 37(2):325-332. PubMed ID: 27236451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral concomitant intravitreal anti-vascular endothelial growth factor injection: Experience in a Nigerian tertiary private eye care facility.
    Okoye O; Okonkwo O; Oderinlo O; Hassan K; Ijasan A
    Niger J Clin Pract; 2016; 19(4):544-8. PubMed ID: 27251975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseases.
    Henry CR; Sisk RA; Tzu JH; Albini TA; Davis JL; Murray TG; Berrocal AM
    J AAPOS; 2015 Dec; 19(6):541-8. PubMed ID: 26691034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the efficacy and side effects of intravitreal versus anterior chamber Bevacizumab injection in neovascular glaucoma patients.
    Ungureanu E; Geamanu A; Popescu V; Dinu I; Grecescu M; Gradinaru S
    J Med Life; 2014; 7 Spec No. 4(Spec Iss 4):68-70. PubMed ID: 27057252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cluster endophthalmitis following multiple intravitreal bevacizumab injections from a single use vial.
    Khan P; Khan L; Mondal P
    Indian J Ophthalmol; 2016 Sep; 64(9):694-696. PubMed ID: 27853027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROGRESSIVE RETINAL DETACHMENT IN INFANTS WITH RETINOPATHY OF PREMATURITY TREATED WITH INTRAVITREAL BEVACIZUMAB OR RANIBIZUMAB.
    Yonekawa Y; Wu WC; Nitulescu CE; Chan RVP; Thanos A; Thomas BJ; Todorich B; Drenser KA; Trese MT; Capone A
    Retina; 2018 Jun; 38(6):1079-1083. PubMed ID: 28471890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M
    Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.
    Zhou S; Gao J; Xu X
    Clin Exp Ophthalmol; 2014; 42(7):637-49. PubMed ID: 24330277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serous retinal detachment after panretinal photocoagulation for proliferative diabetic retinopathy: a case report.
    Schatz P; Aldayel A; Taskintuna I; Abdelkader E; Mura M
    J Med Case Rep; 2017 Sep; 11(1):265. PubMed ID: 28923115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.